Protocol Review Committee

The Protocol Review Committee (PRC) is charged with providing institutional peer review of all cancer-related clinical research protocols, except for trials that have received a previous peer review (e.g. NCI cooperative group trials.)

Before submitting a cancer protocol to the IRB-HSR, it must be reviewed and approved by the PRC (signed approval form must be received).

Click here for the Protocol Review Committee